Germing U - Search Results

1

First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2',4'-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2',4'-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer Therapy.

Mayer S, Prechtl M, Liebfried P, Cadeddu RP, Stuhldreier F, Kohl M, Wenzel F, Stork B, Wesselborg S, Proksch P, Germing U, Haas R, Jäger P. Mayer S, et al. Among authors: germing u. Mar Drugs. 2019 Sep 5;17(9):521. doi: 10.3390/md17090521. Mar Drugs. 2019. PMID: 31491907 Free PMC article.

2

[Aspects of internal medicine].

Haas R, Germing U. Haas R, et al. Among authors: germing u. Radiologe. 2000 Jun;40(6):495-9. doi: 10.1007/s001170050746. Radiologe. 2000. PMID: 10929385 German.

3

[Bone marrow involvement in hematologic neoplasms and solid tumors].

Martin S, Germing U, Kronenwett R, Haas R. Martin S, et al. Among authors: germing u. Radiologe. 2000 Aug;40(8):675-80. doi: 10.1007/s001170050795. Radiologe. 2000. PMID: 11006936 Review. German.

4

Long-term remission after intensive chemotherapy in advanced myelodysplastic syndromes is generally associated with restoration of polyclonal haemopoiesis.

Aivado M, Rong A, Germing U, Gattermann N, Kobbe G, Rieth C, Haas R, Aul C. Aivado M, et al. Among authors: germing u. Br J Haematol. 2000 Sep;110(4):884-6. doi: 10.1046/j.1365-2141.2000.02302.x. Br J Haematol. 2000. PMID: 11054075 Free article.

5

Thalidomide for the treatment of patients with myelodysplastic syndromes.

Strupp C, Germing U, Aivado M, Misgeld E, Haas R, Gattermann N. Strupp C, et al. Among authors: germing u. Leukemia. 2002 Jan;16(1):1-6. doi: 10.1038/sj.leu.2402330. Leukemia. 2002. PMID: 11840256

6

Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports.

Strupp C, Aivado M, Germing U, Gattermann N, Haas R. Strupp C, et al. Among authors: germing u. Leuk Lymphoma. 2002 Jan;43(1):133-7. doi: 10.1080/10428190210190. Leuk Lymphoma. 2002. PMID: 11908717

7

Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning.

Kobbe G, Schneider P, Aivado M, Zohren F, Schubert D, Fenk R, Neumann F, Kronenwett R, Pape H, Rong A, Royer-Pokora B, Hildebrandt B, Germing U, Gattermann N, Heyll A, Haas R. Kobbe G, et al. Among authors: germing u. Exp Hematol. 2002 Nov;30(11):1346-53. doi: 10.1016/s0301-472x(02)00923-2. Exp Hematol. 2002. PMID: 12423689 Free article.

8

Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation.

Kobbe G, Germing U, Aivado M, Zohren F, Schubert D, Strupp C, Pape H, Tenderich G, Körfer R, Storb R, Haas R, Schneider P. Kobbe G, et al. Among authors: germing u. Transplantation. 2002 Oct 27;74(8):1198-200. doi: 10.1097/00007890-200210270-00027. Transplantation. 2002. PMID: 12438973

9

Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.

Strupp C, Gattermann N, Giagounidis A, Aul C, Hildebrandt B, Haas R, Germing U. Strupp C, et al. Among authors: germing u. Leuk Res. 2003 May;27(5):397-404. doi: 10.1016/s0145-2126(02)00220-5. Leuk Res. 2003. PMID: 12620291

10

Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome.

Gattermann N, Wulfert M, Junge B, Germing U, Haas R, Hofhaus G. Gattermann N, et al. Among authors: germing u. Blood. 2004 Feb 15;103(4):1499-502. doi: 10.1182/blood-2003-07-2446. Epub 2003 Oct 23. Blood. 2004. PMID: 14576046 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page